Robert J. Naylor

Robert J. Naylor's AcademicInfluence.com Rankings

Robert J. Naylor

Psychology

#2269

World Rank

#2645

Historical Rank

Behavioral Neuroscience

#12

World Rank

#13

Historical Rank

psychology Degrees

Robert J. Naylor

Biology

#6448

World Rank

#9165

Historical Rank

Neuroscience

#782

World Rank

#815

Historical Rank

biology Degrees

Download Badge

Psychology
Biology

Robert J. Naylor's Degrees

PhD Neuroscience Stanford University

Why Is Robert J. Naylor Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert J. Naylor's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exploration of mice in a black and white test box: Validation as a model of anxiety (1989) (518)
Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain (1987) (340)
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist (1988) (322)
5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue (1989) (259)
The psychopharmacology of 5-HT3 receptors. (1990) (242)
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. (2003) (234)
The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour. (1973) (225)
Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei (1977) (219)
Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. (1972) (196)
The actions of nicotine and cocaine in a mouse model of anxiety (1989) (190)
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates (1990) (189)
5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis (1986) (186)
Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate‐putamen (1977) (182)
Zacopride: anxiolytic profile in rodent and primate models of anxiety (1988) (173)
Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity. (1978) (172)
The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system. (1975) (171)
Serotonergic involvement with neuroleptic catalepsy (1975) (146)
On the mode of action of apomorphine. (1973) (145)
Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei. (1974) (144)
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist (1991) (142)
Serotoninergic modulation of the dopamine response from the nucleus accumbens (1976) (139)
The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain (1976) (134)
Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat (1990) (130)
Antiemetic properties of the 5HT3-receptor antagonist, GR38032F. (1987) (124)
A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. (1976) (123)
Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain. (1990) (122)
Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease (1991) (116)
Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamine. (1974) (116)
1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway (1986) (114)
Neuroanatomical sites of action of 5‐HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse (1989) (111)
Anxiolytic potential of 5-HT3 receptor antagonists. (1992) (110)
The hypotheses of different dopamine receptor mechanisms. (1981) (110)
Neuroleptic and non-neuroleptic catalepsy. (1973) (108)
Zacopride, a potent 5‐HT3 antagonist (1988) (108)
[3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition Sites (1988) (106)
Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas. (1975) (106)
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse (1990) (105)
Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. (1976) (98)
Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice. (1981) (96)
Anxiolytic effects of CCK-B antagonists (1991) (96)
On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity (1974) (94)
Sites of action of ondansetron to inhibit withdrawal from drugs of abuse (1990) (94)
Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro (1989) (93)
Actions of sulpiride and tiapride in a simple model of anxiety in mice (1987) (92)
Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors? (1980) (91)
Cognitive enhancing actions of PD123177 detected in a mouse habituation paradigm. (1990) (91)
Mesolimbic involvement with behavioural effects indicating antipsychotic activity. (1974) (89)
5-HT3 receptors. (2004) (89)
Design of agents for stimulation of neostriatal dopaminergic mechanisms (1974) (89)
5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders. (1990) (89)
The substantia nigra and stereotyped behaviour. (1972) (88)
Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain Tissue (1989) (88)
Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs (1987) (87)
5‐Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205–930 in the guinea‐pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in‐vivo (1985) (83)
The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition (1989) (83)
Mesolimbic and Extrapyramidal Sites for the Mediation of Stereotyped Behaviour Patterns and Hyperactivity by Amphetamine and Apomorphine in the Rat (1977) (82)
Modification of the behavioural changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus. (1972) (77)
Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. (1972) (77)
The effect of ondansetron on cognitive performance in the marmoset (1991) (76)
The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret (1996) (75)
The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI) (1979) (74)
The effect of GR38032F, novel 5‐HT3‐receptor antagonist on gastric emptying in the guinea‐pig (1987) (70)
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. (1991) (70)
Angiotensin-converting enzyme inhibition, angiotensin, and cognition. (1992) (70)
Neuropharmacological studies on the neuroleptic potential of domperidone (R33812) (1979) (68)
Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets (2012) (68)
The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety. (1993) (67)
Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition (1990) (67)
Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat (1982) (66)
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset (1990) (64)
An interaction of ondansetron and dexamethasone antagonizing cisplatin‐induced acute and delayed emesis in the ferret (1996) (64)
Angiotensin II Inhibits Cortical Cholinergic Function: Implications for Cognition (1990) (63)
Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset (1992) (63)
The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam (1989) (63)
Evidence for a 5‐HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5‐HT in the guinea pig isolated ileum (1997) (62)
The involvement of dopaminergic systems with the stereotyped behaviour patterns induced by methylphenidate (1974) (60)
Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. (1976) (60)
Actions of Buspirone in a Putative Model of Anxiety in the Mouse (1988) (59)
The actions of fentanyl to inhibit drug-induced emesis (1991) (59)
Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. (1994) (58)
Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. (1996) (58)
Neuroleptic antagonism of dyskinetic phenomena. (1975) (58)
Hyperactivity response to apomorphine and amphetamine in the mouse: the importance of the nucleus accumbens and caudate‐putamen (1979) (58)
Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret (1994) (58)
Actions of dopaminergic agonists on motor function. (1975) (57)
SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors. (1984) (56)
The induction of catalepsy and hyperactivity by morphine administered directly into the nucleus accumbens of rats. (1978) (56)
A study of the changes in motor behaviour caused by TRH on intracerebral injection. (1979) (55)
The Anxiolytic and Anxiogenic Actions of Ethanol in a Mouse Model (1988) (54)
The differential activities of R(+)- and S(−)-zacopride as 5-HT3 receptor antagonists (1990) (54)
Astra Award Lecture. The psychopharmacology of 5-HT3 receptors. (1992) (53)
Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset. (1992) (53)
Mechanisms of tremor induction by harmine. (1974) (53)
Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting. (1977) (52)
Neuropharmacology of emesis and its relevance to anti-emetic therapy (1998) (50)
The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents. (1974) (50)
Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret (1988) (49)
Behavioural effects of anxiogenic agents in the common marmoset (1992) (48)
Behavioural interactions between 5‐hydroxytryptophan, neuroleptic agents and 5‐HT receptor antagonists in modifying rodent responding to aversive situations (1995) (47)
The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. (1997) (47)
5‐HT7 receptors mediate the inhibitory effect of 5‐HT on peristalsis in the isolated guinea‐pig ileum (2003) (46)
Decreasing paediatric prescribing errors in a district general hospital (2008) (46)
Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum. (1978) (45)
Differential modulation of extracellular levels of 5‐hydroxytryptamine in the rat frontal cortex by (R)‐ and (S)‐zacopride (1992) (45)
Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist. (1990) (45)
Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine (1975) (43)
Identification of 5‐HT3 recognition sites in the ferret area postrema (1988) (43)
Identification and distribution of 5-HT3 recognition sites within the human brainstem (1990) (43)
Fluphenazine, ICS 205–930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret (1990) (43)
Agonist interactions with 5‐HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands (1992) (42)
Does an endogenous methylpyridinium analogue cause Parkinson's disease? (1985) (42)
The Selective ς2-Ligand Lu 28-179 Has Potent Anxiolytic-Like Effects in Rodents (1997) (40)
On the involvement of the caudate-putamen, globus pallidus and substantia nigra with neuroleptic and cholinergic modification of locomotor activity. (1972) (40)
The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy. (1971) (40)
Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig. (1975) (39)
Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine. (1990) (39)
Withdrawal syndrome following subchronic treatment with anxiolytic agents (1987) (38)
Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects. (1979) (38)
Toxic effects of solstitialin a 13-acetate and cynaropicrin from Centaurea solstitialis L. (asteraceae) in cell cultures of foetal rat brain (1992) (36)
Neuropharmacology of Emesis and Its Relevance to Antiemetic Therapy (1998) (36)
Identification and distribution of 5‐HT3 recognition sites in the rat gastrointestinal tract (1992) (36)
The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats (1993) (35)
Correlation between multitest and single test catalepsy assessment (1978) (35)
The 6‐hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6‐hydroxydopamine (1975) (35)
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety (1985) (35)
Effect of Aversive Stimulation on 5-Hydroxytryptamine and Dopamine Metabolism in the Rat Brain (1997) (35)
The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function. (1983) (34)
Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens. (1976) (34)
Laterality of dopamine function and neuroleptic action in the amygdala in the rat (1985) (34)
Neurotoxic Sesquiterpenoids from the Yellow Star Thistle Centaurea solstitialis L. (Asteraceae) (1991) (34)
Possible involvement of a noradrenergic area of the amygdala with stereotyped behaviour (1972) (34)
Pharmacological characterization of the 5‐hydroxytryptamine receptor mediating relaxation in the rat isolated ileum (1996) (33)
Stimulation of rat spontaneous locomotion by low doses of haloperidol and (-)-sulpiride: importance of animal selection and measurement technique. (1983) (33)
A comparison of dopamine agonist action to inhibit locomotor activity and to induce stereotyped behaviour in the mouse. (1984) (33)
The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret (1996) (33)
(−)N-(Chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding (1980) (33)
Hyperactivity induced by injection of dopamine into the accumbens nucleus: Actions and interactions of neuroleptic, cholinomimetic and cholinolytic agents (1979) (32)
The mesolimbic system, denervation and the climbing response in the mouse. (1980) (32)
Variables of Movement Amplitude and Frequency in the Development of Motion Sickness in Suncus murinus (1999) (32)
Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model. (1992) (32)
Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test. (1994) (32)
Preparation and biological actions of some symmetrically N,N-disubstituted dopamines. (1978) (32)
On the ability of domperidone to selectively inhibit catecholamine‐induced relaxation of circular smooth muscle of guinea‐pig stomach (1982) (31)
Pharmacological characterization of the 5‐HT receptor‐mediated contraction in the mouse isolated ileum (2000) (31)
The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus. (2008) (31)
The influence of 5‐HT2 and 5‐HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test (1997) (31)
The role of the raphé and extrapyramidal nuclei in the stereotyped and circling responses to quipazine (1975) (31)
Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. (1990) (30)
Neuropharmacology of emesis in relation to clinical response. (1992) (30)
Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines. (1977) (29)
The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus (2002) (29)
The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice antagonism by monoamine oxidase inhibitors Antagonism by monoamine oxidase inhibitors (1986) (29)
Topographical analysis of the actions of 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig (1980) (29)
Modification of amphetamine effects by intracerebrally administered anticholinergic agents. (1972) (29)
The distribution of 5-HT3 recognition sites in the marmoset brain. (1992) (29)
Pharmacology of ondansetron. (1992) (28)
Neuropharmacology of 5-HT3 Receptor Ligands (2000) (28)
Differential actions of substituted benzamides on pre‐ and postsynaptic dopamine receptor mechanisms in the nucleus accumbens (1980) (28)
Nomifensine: A potent dopaminergic agonist of antiparkinson potential (2004) (28)
Involvement of mesolimbic and extrapyramidal nuclei in the motor depressant action of narcotic drugs (1978) (28)
Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline. (1980) (28)
Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew). (1999) (27)
A study of drug action on normal and denervated striatal mechanisms. (1979) (27)
Investigations into the nature of the peri-oral movements induced by 2-(N-N-dipropyl) amino-5,6-dihydroxytetralin. (1977) (26)
Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias. (1976) (26)
Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement. (1982) (26)
The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei. (1976) (26)
Differential activities of some benzamide derivatives on peripheral and intracerebral administration (1978) (26)
Circling behaviour produced by asymmetric medial raphe nuclei lesions in rats (1976) (25)
The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour. (1992) (25)
The antidyskinetic action of dihomo‐γ‐linolenic acid in the rodent (1984) (25)
The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour. (1983) (25)
Actions of ORG 5222 as a novel psychotropic agent (1990) (25)
Serotonergic involvement with the stereotypy/catalepsy induced by morphine‐like agents in the rat (1975) (24)
Neuroleptic interaction with the serotoninergic‐dopaminergic mechanisms in the nucleus accumbens (1978) (24)
The nucleus amygdaloideus centralis and neuroleptic activity in the rat. (1974) (24)
On the ability of N‐chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms (1980) (24)
The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse (1988) (24)
Ketotifen and its analogues reduce aversive responding in the rodent (1990) (24)
5‐HT3 and 5‐HT4 receptor‐mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum (1996) (24)
Further aspects of nomifensine pharmacology. (1977) (24)
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area (1986) (23)
A central site of action for benzamide facilitation of gastric emptying. (1983) (23)
The pharmacology of the 5‐HT4 receptor (1993) (23)
5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat. (1990) (23)
5-Hydroxytryptamine M-receptor antagonism in the hypothalamus facilitates gastric emptying in the guinea-pig (1986) (23)
The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus (2006) (23)
An HPLC assay procedure of sensitivity and stability for measurement of acetylcholine and choline in neuronal tissue (1987) (22)
Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease. (1990) (22)
The distribution of haloperidol in rat brain. (1969) (21)
The effects of umespirone as a potential anxiolytic and antipsychotic agent (1991) (21)
Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area (1990) (21)
Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives (1978) (21)
Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action (2004) (21)
Apomorphine as an antagonist of the dopamine response from the nucleus accumbens (1976) (20)
The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret. (1997) (20)
Ondansetron fails to attenuate a scopolamine-induced deficit in a Stone maze task. (1994) (20)
Chronic aspirin ingestion improves spatial learning in adult and aged rats (2002) (19)
Neuronally mediated contraction responses of guinea-pig stomach smooth muscle preparations: modification by benzamide derivatives does not reflect a dopamine antagonist action. (1984) (19)
A comparison of circling models for the detection of antiparkinson activity (2004) (19)
Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation? (1983) (19)
The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat (2004) (19)
Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrain (1983) (19)
5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse (2004) (18)
The effect of 5-HT receptor ligands on the uptake of [3H]5-hydroxytryptamine into rat cortical synaptosomes. (1993) (18)
The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents. (1972) (18)
Catecholamine‐induced relaxation and contraction of the lower oesophageal and pyloric sphincters of guinea‐pig stomach: modification by domperidone (1982) (18)
Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi (1975) (18)
Denervation in the dopaminergic mesolimbic system: Functional changes followed using (−) N-n-propylnorapomorphine depend on the basal activity levels of rats (1980) (18)
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret. (2008) (17)
Anxiolytic‐like actions of anpirtoline in a mouse light‐dark aversion paradigm (1992) (17)
Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion (1984) (17)
On the preferred rotameric conformation for dopamine agonist action: an illusory quest? (1982) (17)
The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. (1997) (17)
Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect? (2004) (16)
5‐Hydroxytryptamine can antagonize the ability of metoclopramide and SCH 23390 to enhance electrical field stimulation‐evoked contractions of guinea‐pig isolated stomach muscle (1985) (16)
Sertindole: A limbic selective neuroleptic with potent anxiolytic effects (1995) (16)
Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamine. (1982) (15)
The role of the substantia nigra in the locomotor stimulant action of amphetamine (1973) (15)
Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens (2004) (15)
Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons. (1980) (15)
The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function (2005) (15)
On the importance of mesolimbic mechanisms for the control of apomorphine induced climbing behaviour in the mouse [proceedings]. (1980) (14)
Opioid receptor involvement in the adaptation to motion sickness in Suncus murinus (2001) (14)
The importance of extrapyramidal function for the induction and antagonism of harmine tremor. (1975) (14)
Cholinergic modification of abnormal involuntary movements induced in the guinea‐pig by intrastriatal dopamine (1975) (14)
Effect of sertindole on raised mesolimbic dopaminergic activity in the rat (1994) (14)
Serotonin and psychiatric disorders. A key to new therapeutic approaches. (1992) (13)
N-Alkyl derivatives of (+/-)-alpha-methyldopamine. (1979) (13)
A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat (1974) (13)
Characterization of the 5‐hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus (1999) (13)
The actions of (−)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens (1990) (13)
5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions. (1981) (13)
The action of dazopride to enhance gastric emptying and block emesis (1987) (13)
Inhibition and facilitation of motor responding of the mouse by actions of dopamine agonists in the forebrain (1984) (12)
An analysis of the hypothalamic sites at which substituted benzamide drugs act to facilitate gastric emptying in the guinea-pig (1985) (12)
The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse (1990) (12)
Motor inhibition induced by aporphine derivatives in the mouse (1983) (12)
Changes in dopamine‐dependent motor behaviour caused by propranolol and its isomers (1978) (12)
Mechanisms of dyskinesia induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat (1976) (12)
A central site of dopamine agonist action to modify gastric secretion in the rat. (1985) (12)
Studies on the dopamine agonist properties of 8‐amino‐2‐methyl‐4‐(3,4‐dihydroxyphenyl)‐1,2,3,4‐tetrahydroisoquinoline, a derivative of nomifensine (1978) (12)
The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine (1985) (11)
CEREBRAL DOPAMINE AGONIST PROPERTIES OF SOME 2-AMINOTETRALIN DERIVATIVES AFTER PERIPHERAL AND INTRACEREBRAL ADMINISTRATION (1977) (11)
N-Isopropyl derivatives of dopamine and 5,6-dihydroxy-2-aminotetralin. (1975) (11)
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment (1985) (11)
Pharmacological properties and functions of central 5-HT3 receptors. (1991) (11)
Behavioural actions of neuroleptics are not reduced by hypophysectomy (1982) (11)
Characterisation of 5-HT2 receptor subtypes in the Suncus murinus intestine. (1999) (11)
Biochemical correlates of motor changes caused by the manipulation of dopamine function in the substantia nigra of the mouse (1985) (11)
Specific asymmetric behaviour induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms (2004) (10)
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra (1986) (10)
Serotonin-independent model of cisplatin-induced emesis in the ferret. (1998) (10)
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue (1991) (10)
Behavioural correlates of modified dopaminergic/anticholinergic responses following chronic treatment with neuroleptic agents of differing activity spectra. (1978) (10)
Acute and chronic arecoline: Effects on a scopolamine-induced deficit in complex maze learning (1996) (9)
Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse (2004) (9)
Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives (1976) (9)
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan) (1975) (9)
Mechanism of action of apomorphine on rat gastric secretion. (1985) (9)
BENZTROPINE INHIBITS TOXICITY OF MPTP IN MICE (1985) (9)
Emesis and anti-emesis. (1994) (9)
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus (2011) (9)
Dopamine agonist and antagonist activities of piribedil (ET495) and its metabolites (2004) (9)
Modification of the behavioural changes induced by haloperidol in the ray by lesions in the caudate nucleus, the caudate-putamen and globus pallidus. (1972) (9)
An intracerebral injection study on the role of striatal dopamine and 5-hydroxytryptamine in the production of tremor by harmine (1976) (9)
Behavioural consequences of the infusion of dopamine into the nucleus accumbens of the common marmoset (Callithrix jacchus) (1987) (9)
Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent (1985) (8)
Relevance of the rodent area postrema to dopamine‐dependent behavioural effects (1981) (8)
The effects of 5-HT3 receptor antagonists in models of dependency and withdrawal. (1993) (8)
Differential effects of (3,4‐dihydroxyphenylamino)‐2‐imidazoline (DPI) on hyperactivity responses to dopamine agonists injected into the nucleus accumbens (1979) (8)
Field stimulation-induced responses of circular smooth muscle from guinea-pig stomach (1983) (8)
Aged Stone maze-impaired rats exhibit reduced striatal muscarinic receptor densities. (1994) (8)
A functional role for 5-HT4 receptors in the brain? (1993) (8)
Reduction in Spontaneous Locomotor Activity by Purported Dopamine Agonists: an Analysis of the Site and Mechanism of Action (1982) (7)
Biphasic changes in motor behaviour following morphine injection into the nucleus accumbens [proceedings]. (1976) (7)
Use of the intracerebral injection technique to elucidate mechanisms of apomorphine climbing and its antagonism in the mouse (2004) (7)
Gabaminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)animo-5,6-dihydroxytetralin. (1978) (7)
5-HT3 Receptors in the Central Nervous System (1989) (7)
Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings]. (1978) (7)
Dopamine antagonistic effects of a series of analogues of oxiperomide and spiroxatrine measured behaviourally in the rodent (1978) (7)
Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: Behavioural correlates in rodent and primate (1987) (7)
Neuropharmacological manipulations with MPTP. (1986) (6)
Pharmacological comparison of the rat and guinea-pig cortical high affinity 5-hydroxytryptamine uptake system. (1992) (6)
Modulation of 5‐HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5‐hydroxytryptamine (2002) (6)
PREPARATION AND BIOLOGICAL ACTIONS OF SOME SYMMETRICALLY N,N-DISUBSTITUTED DOPAMINES (1978) (6)
Modification of electrical field stimulation‐induced contractions in the guinea‐pig ileum by metoclopramide and ICS 205–930 depends on the integrity of the mucosa (1986) (6)
Differential interactions of picrotoxin with the biting behaviour caused by 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin and apomorphine in the guinea pig: a study of the mechanisms involved. (1978) (6)
Influence of 5-HT3 Receptor Antagonists on Limbic-Cortical Circuitry (1991) (5)
The emetic action of copper sulphate in the ferret (1990) (5)
Tiapride binds to mouse striatal tissue pre‐exposed to dopamine stimulation (1980) (5)
Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellum (1992) (5)
Pharmacological Models in the Development of Antipsychotic Drugs — New Strategies (1991) (5)
Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem (1990) (5)
Nausea and Vomiting (2002) (5)
The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex (1990) (5)
facilitation oftheemptying phaseoftheperistaltic reflex inthemarmosetisolated ileum (1996) (5)
The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings]. (1979) (4)
SCH 23390 can enhance field stimulation‐induced contractions of longitudinal smooth muscle from guinea‐pig stomach (1984) (4)
A simple technique and apparatus for sectioning rat brain in the plane of a lesion track. (1971) (4)
The relative abilities of MPTP and MPP+ to compete with [3H]dopamine for the rat and marmoset striatal dopamine uptake site. (1990) (4)
Biochemical changes caused by the infusion into the substantia nigra of the rat of MPTP and related compounds which antagonise dihydropteridine reductase (1986) (4)
The Actions of Fenfluramine and Interaction with 5‐HT3 Receptor‐Antagonists to Inhibit Emesis in the Ferret (1990) (4)
Modulation of emesis by 5HT1A receptors (1994) (4)
APORPHINES. 21. DOPAMINERGIC ACTIVITY OF APORPHINE AND BENZYLISOQUINOLINE DERIVATIVES. SYNTHESIS OF 8-HYDROXYAPORPHINES AND 1-(HYDROXYBENZYL)-2-N-PROPYL-1,2,3,4-TETRAHYDROISOQUINOLINES (1977) (4)
A PRIMATE MODEL FOR THE ASSESSMENT OF ANXIOLYTIC DRUG ACTION (2007) (4)
Changes in dopamine agonist and antagonist activity floowing temporary inactivation of the neostriatum (2004) (4)
Behavioural Characterization of Neuroleptic Properties in the Rodent (1977) (4)
Benzamide action at α2-adrenoceptors modifies catecholamine-induced contraction and relaxation of circular smooth muscle from guinea-pig stomach (1982) (4)
Whose degree is it anyway? : why, how and where universities are failing our students (2007) (4)
Modulation of dopamine function by glycine in the nucleus accumbens of the brain of the rat (1986) (3)
Pharmacological characterization of endothelin receptors‐mediated contraction in the mouse isolated proximal and distal colon (2006) (3)
Neurotoxic Sesquiterpene Lactones from the Yellow Star ThistleCentaurea solstitialis: Large-Scale Isolation and Biological Activity (1991) (3)
Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation. (1981) (3)
Aminoalkylindoles: atypical dopamine antagonists (1983) (3)
Ascorbic acid and membrane ageing: critical determinants of the in‐vitro binding of [3]ADTN to rat striatal tissue (1983) (3)
New Antidementia Molecules Which Selectively Influence Serotonin Receptor Subtypes (1993) (3)
5-HT antagonists inhibit neuroleptic and morphine antagonism of the hyperactivity induced by DA from the nucleus accumbens [proceedings]. (1977) (3)
The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent. (1984) (3)
A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections (1983) (3)
N-ALKYL DERIVATIVES OF (.+-.)-α-METHYLDOPAMINE (1980) (3)
A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings]. (1979) (3)
THE EFFECTS OF SEROTONIN RECEPTOR ANTAGONISTS ON CONTRACTION AND RELAXATION RESPONSES INDUCED BY ELECTRICAL STIMULATION IN THE RAT SMALL INTESTINE (2014) (2)
MPTP Infusion into Rat Substantia Nigra Causes Hypokinesia and Bradykinesia which are Reversed by L-Dopa Treatment (1986) (2)
The sites and mechanisms of action of 2-DI-n-propylamino-5,6-dihydroxytetralin in the hypothalamus of the rat to modify gastric secretion (1986) (2)
Desenkephalin-γ-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset (1989) (2)
PRECLINICAL EVIDENCE FOR THE ANXIOLYTIC POTENTIAL OF E-4424 (1992) (2)
The mechanism of action of dopamine to inhibit field stimulation-induced contractions of guinea pig stomach strips (1984) (2)
CONGENERS OF THE β CONFORMER OF DOPAMINE DERIVED FROM CIS- AND TRANS-OCTAHYDROBENZO(F)QUINOLINE AND TRANS-OCTAHYDROBENZO(G)QUINOLINE (1980) (2)
Recent developments in the drug treatment of schizophrenia (1980) (2)
Benzamide action at alpha 2-adrenoceptors modifies catecholamine-induced contraction and relaxation of circular smooth muscle from guinea-pig stomach. (1982) (2)
Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway. (1975) (2)
Unilateral striatal dopamine denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour (1984) (2)
Catecholamines act as alpha 2-adrenoceptors to cause contraction of circular smooth muscle of guinea-pig stomach. (1982) (2)
Angiotensin II inhibits cortical cholinergic function (1990) (1)
D-1 and D-2 dopamine agonist - antagonist action in the nuclius accumbens to modify mouse spontaneous climbing behaviour (1984) (1)
ONDANSETRN IN THE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING (1992) (1)
2815 – TIAPRIDE: A BENZAMIDE DERIVATIVE HAVING A UNIQUE ACTIVITY SPECTRUM (1978) (1)
Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings]. (1979) (1)
5-HT3 receptor antagonists, cognition and schizophrenia (1994) (1)
Problematical binding of [3H]5-hydroxytryptamine to rat gut myenteric membranes. (1993) (1)
Modulation of amphetamine hyperactivity by DPI injected into rat nucleus accumbens [proceedings]. (1978) (1)
Characterisation of [3H]SQ29,852 recognition sites in rodent brain (1990) (1)
Use of the mouse circling model to demonstrate enhanced striatal actions for oxiperomide and tiapride following denervation [proceedings]. (1979) (1)
SYNTHESIS AND DOPAMINERGIC PROPERTIES OF SOME EXO- AND ENDO-2-AMINOBENZONORBORNENES DESIGNED AS RIGID ANALOGS OF DOPAMINE (1982) (1)
Dihomo-γ-linolenic acid, prostaglandins and dyskinesias (1986) (1)
The effect of fluoxetine on electrical field stimulation-induced responses in the isolated rat small intestine. (2010) (1)
Apomorphine contracts and relaxes circular smooth muscle of guinea-pig stomach via action on adrenoceptor mechanisms (1982) (0)
Development of New Antiemetics (1994) (0)
The Modulation of Mesolimbic Dopamine Mechanisms via Serotonin and GABA (1978) (0)
Metoclopramide and SCH 23390 can Enhance Cholinergic Mediated Contractions of Guinea Pig Bladder (1986) (0)
Changes in dopamine receptor status after denervation or chronic receptor stimulation [proceedings]. (1979) (0)
Brain penetration is necessary for the antiemetic activity of NK1 receptor antagonists (2003) (0)
Detection of the behavioural effects of anxiogenic agents in a “low anxiety” model utilising the common marmoset (callihrix jacchus) (1990) (0)
Evidence for A1 adenosine receptor–mediated inhibition of peristalsis in the guinea-pig isolated ileum (2008) (0)
The Antiemetic Properties of 5-HT3Receptor Antagonists (1993) (0)
DIFFERENTIAL ACTIVITIES OF (R)- AND (S)-ZACOPRIDE TO MODIFY EXTRACELLULAR LEVELS OF 5-HYDROXYTRYPTAMINE IN THE RAT FRONTAL CORTEX (1992) (0)
556 – THE MODULATION OF MESOLIMBIC DOPAMINE MECHANISMS VIA SEROTONIN AND GABA (1978) (0)
615 – INVOLVEMENT OF 5-HYDROXYTRYPTAMINE MECHANISMS WITHIN THE NUCLEUS ACCUMBENS IN MORPHINE INDUCED CATALEPSY (1978) (0)
ASPIRIN BRINGS ABOUT ITS BENEFICIAL EFFECTS BY MODIFICATION OF PLASMA CHOLESTEROL CONCENTRATIONS (2012) (0)
Contents, Supplement 1, 1996 (1996) (0)
Modulation of [3H]5-hydroxytryptamine release from guinea-pig cortex via the 5-HT1 site (1990) (0)
Effect of ketamine/xylazine anaesthesia on 5-hydroxytryptamine uptake in guinea pig cerebral cortex (1990) (0)
Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives: Edited by Paul Willner; Published 1991 Cambridge University Press, Cambridge; xiii + 540 pages; ISBN 0 521 39192 X £80.00 UK, $150.00 USA (1992) (0)
The effect of anxiogenic agents on the response of marmosets (callithrix jacchus) to a “human threat” (1990) (0)
Neurotoxic Sesquiterpenoids from the Yellow Star Thistle Centaurea solstitialis L. (Asteraceae). (1991) (0)
Dihomo-gamma-linolenic acid, prostaglandins and dyskinesias. (1986) (0)
The behavioural pharmacology of the 5-HT3 receptor antagonists (1993) (0)
Neurochemical changes in cortical, limbic and extrapyramidal brain areas following stimulation of the ventral tegmental area (1990) (0)
The selective toxicity of MPTP on rat mesencephalic neuronal cell culture (1990) (0)
Animal models of memory impairment (1994) (0)
Application of N- (2- (diethylamino) ethyl) -2-methoxy-4 ((1-H-4,5-dihydro-2-imidazolyl) amino) -5-chlorobenzamid as anxiolytic and antipsychotic agents. (1987) (0)
Neurochemical aspects of the opioid-induced ‘catatonia’ (1982) (0)
5,7-DIHYDROXY-2-AMINOTETRALIN DERIVATIVES: SYNTHESIS AND ASSESSMENT OF DOPAMINERGIC AND ADRENERGIC ACTIONS (1981) (0)
N-ISOPROPYL DERIVATIVES OF DOPAMINE AND 5,6-DIHYDROXY-2-AMINOTETRALIN (1976) (0)
Prostaglandins can Selectively Modify Striatal Dopamine Function (1986) (0)
Application of substituted benzamides as gastromoteurs (1988) (0)
New ortho anisamides, their process of preparation and their therapeutic applications (1985) (0)
CONTRIBUTIONS BY TITLE ONLY (1988) (0)
RIGID CONGENERS OF DOPAMINE BASED ON OCTAHYDROBENZO(F)QUINOLINE: PERIPHERAL AND CENTRAL EFFECTS (1979) (0)
ASPIRIN BRINGS ABOUT ITS BENEFICIAL EFFECTS BY MODIFICATION OF DIASTOLIC BLOOD PRESSURE OF SMOKERS (2012) (0)
BEHAVIOURAL CONSEQUENCES OF WITHDRAWAL FROM DRUGS OF ABUSE (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert J. Naylor?

Robert J. Naylor is affiliated with the following schools:

University of Bradford

Robert J. Naylor's Academic­Influence.com Rankings

Robert J. Naylor's Degrees

Why Is Robert J. Naylor Influential?

Robert J. Naylor's Published Works

Published Works

What Schools Are Affiliated With Robert J. Naylor?

Robert J. Naylor's AcademicInfluence.com Rankings